Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Trading exchanges
Trading exchanges
SWX
Products 1 to 7 of 7
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Antibiotic - EV-035
by
Emergent Biosolutions, Inc.
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Switzerland
Intended consumer:
Government
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Finished Product
EveNootkatone
by
Evolva
Biotech components:
Plant
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
EverSweet™
by
Evolva
+
Cargill
Biotech components:
Plant
Business models:
B2B
+
B2C
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/09/13 15:54 (7 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
Pomecin
by
Evolva
Biotech components:
Plant
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/02 15:44 (7 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
Resveratrol
by
Evolva
Biotech components:
Microbe
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Food
+
Personal Care (Topical)
+
Personal Care (Ingested)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
Stevia
by
Evolva
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Finished Product
Vanillin
by
Evolva
Biotech components:
Microbe
+
Fungus
Business models:
B2B
Country of production:
USA
Country of distribution:
Switzerland
+
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
